Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
‘De werk-privé balans is beter, maar de zorg is stroperiger’
mei 2024
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
okt 2021 | Uro-oncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
mrt 2024
nov 2023
sep 2023